Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com 0 Related Posts Significant Enlargement of Exploration Program September 15, 2025 Locksley Resources LimitedSignificant Enlargement of Exploration Program September 15, 2025 Prismo Metals Identifies Porphyry Style Mineralization at Silver King September 15, 2025